A524 CLINICAL CORRELATION OF NON-INVASIVE MEASUREMENT OF CARDIAC OUTPUT AND THERMODILUTION TECHNIQUE AMONG SURGICAL INTENSIVE CARE PATIENTS

1990 ◽  
Vol 73 (3A) ◽  
pp. NA-NA
Author(s):  
J. H. Silverstein ◽  
W. Welkowitz ◽  
Y. Qi ◽  
Q. Cui ◽  
A. Ababs ◽  
...  
2012 ◽  
Vol 109 (6) ◽  
pp. 879-886 ◽  
Author(s):  
B. Bataille ◽  
M. Bertuit ◽  
M. Mora ◽  
M. Mazerolles ◽  
P. Cocquet ◽  
...  

2021 ◽  
Author(s):  
Cornelis Slagt ◽  
Eduard Johannes Spoelder ◽  
Marijn Cornelia Theresia Tacken ◽  
Maartje Frijlink ◽  
Sjoerd Servaas ◽  
...  

Abstract Background: During the COVID-19 pandemic in The Netherlands, critically ill ventilated COVID-19 patients were not only transferred between hospitals by ambulance, but also by the Helicopter Emergency Medical Service (HEMS). To date, little is known about the impact of helicopter transport on critically ill patients, and COVID-19 patients in particular. This study was conducted to explore the impact of inter-hospital helicopter transfer on vital signs of mechanically ventilated severe COVID-19 intensive care patients, with special focus on take-off, midflight, and landing. Methods: All ventilated critically ill COVID-19 patients who were transported between April 2020 and June 2021 by the Dutch ‘Lifeliner 5’ HEMS team and who were fully monitored including non-invasive cardiac output, were included in this study. Three 10 minute timeframes (take-off, midflight and landing) were defined for analysis. Continuous data of vital parameters heartrate, peripheral oxygen saturation, arterial blood pressure, end-tidal CO2 and non-invasive cardiac output using electrical cardiometry were collected and stored at a 1 minute interval. Data were analysed for differences over time within the timeframes using 1-way analysis of variance. Significant differences were checked for clinical relevance. Results: Ninety-eight patients were included in the analysis. During take-off an increase was noticed in cardiac output (from 6.7 to 8.1 Lmin-1; P<0.0001) which was determined by a decrease in systemic vascular resistance (from 1068 to 750 dyne·s·cm−5, P<0.0001) accompanied by an increase in stroke volume (from 92.0 to 110.2 ml, P<0.0001). Other parameters were unchanged during take-off and mid-flight. During the landing cardiac output and stroke volume slightly decreased (from 7.9 to 7.1 Lmin-1, P<0.0001 and from 108.3 to 100.6 ml, P<0.0001 respectively) and total systemic vascular resistance increased (P<0.0001). Though statistically significant, the found changes were small and not clinically relevant to the medical status of the patients as judged by the attending physicians. Conclusions: Interhospital helicopter transfer of ventilated intensive care patients with COVID-19 can be performed safely and does not result in clinically relevant changes in vital signs. This study this has been assessed by the medical ethical committee Arnhem-Nijmegen, the Netherlands (identifier 2021-7313). The committee waived the need for informed consent. The study was registered at www.trialregister.nl (identifier NL9307).


2019 ◽  
Vol 11 (1) ◽  
Author(s):  
M. J. Blans ◽  
F. H. Bosch ◽  
J. G. van der Hoeven

Abstract Background In critical care medicine, the use of transthoracic echo (TTE) is expanding. TTE can be used to measure dynamic parameters such as cardiac output (CO). An important asset of TTE is that it is a non-invasive technique. The Probefix is an external ultrasound holder strapped to the patient which makes it possible to measure CO using TTE in a fixed position possibly making the CO measurements more accurate compared to separate TTE CO measurements. The feasibility of the use of the Probefix to measure CO before and after a passive leg raising test (PLR) was studied. Intensive care patients were included after detection of hypovolemia using Flotrac. Endpoints were the possibility to use Probefix. Also CO measurements with and without the use of Probefix, before and after a PLR were compared to the CO measurements using Flotrac. Side effects in terms of skin alterations after the use of Probefix and patient’s comments on (dis)comfort were evaluated. Results Ten patients were included; in eight patients, sufficient recordings with the use of Probefix could be obtained. Using Bland–Altman plots, no difference was found in accuracy of measurements of CO with or without the use of Probefix before and after a PLR compared to Flotrac generated CO. There were only mild and temporary skin effects of the use of Probefix. Conclusions In this small feasibility study, the Probefix could be used in eight out of ten intensive care patients. The use of Probefix did not result in more or less accurate CO measurements compared to manually recorded TTE CO measurements. We suggest that larger studies on the use of Probefix in intensive care patients are needed.


1986 ◽  
Vol 14 (4) ◽  
pp. 294-297 ◽  
Author(s):  
JOHAN F. VANDENBOGAERDE ◽  
RUDY G. SCHELDEWAERT ◽  
DIRK L. RIJCKAERT ◽  
DENIS L. CLEMENT ◽  
FRANCIS A. COLARDYN

Sign in / Sign up

Export Citation Format

Share Document